Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    NCT01900665
Previous Study | Return to List | Next Study

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo (EXPEDITION 3)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Eli Lilly and Company
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT01900665
First received: July 12, 2013
Last updated: October 10, 2014
Last verified: October 2014
  Purpose

To test the idea that solanezumab will slow the cognitive and functional decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.


Condition Intervention Phase
Alzheimer's Disease
Drug: Solanezumab
Drug: Placebo
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo

Resource links provided by NLM:


Further study details as provided by Eli Lilly and Company:

Primary Outcome Measures:
  • Change from Baseline in Alzheimer's Disease Assessment Scale-Cognitive 14 Item Subscore (ADAS-Cog14) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Alzheimer's Disease Cooperative Study- Instrumental Activities of Daily Living (ADCS-iADL) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Change from Baseline in Alzheimer's Disease Assessment Scale-Cognitive 11 Item Subscore (ADAS-Cog11) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Mini-Mental State Examination (MMSE) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory (ADCS-ADL) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Functional Activities Questionnaire (FAQ) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Clinical Dementia Rating-Sum of Boxes (CDR-SB) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Neuropsychiatric Inventory (NPI) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Resource Utilization in Dementia-Lite (RUD-Lite) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Quality of Life in Alzheimer's Disease (QoL-AD) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in 5-Dimensional EuroQol Quality of Life Scale Proxy Version (EQ-5D Proxy) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Proportion of Cognitive and Functional Responders [ Time Frame: Baseline through Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Plasma Amyloid-Beta (Aβ) Species [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in volumetric Magnetic Resonance Imaging (vMRI) [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Pharmacokinetics (PK): Area Under the Concentration Time Curve (AUC) of Solanezumab (LY2062430) [ Time Frame: Baseline through Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Florbetapir Positron Emission Tomography (PET) Scan [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]
  • Change from Baseline in Cerebrospinal Fluid (CSF) Aβ Levels [ Time Frame: Baseline, Week 80 ] [ Designated as safety issue: No ]

Estimated Enrollment: 2100
Study Start Date: July 2013
Estimated Study Completion Date: November 2018
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Solanezumab
Solanezumab 400 milligram (mg) every 4 weeks for 18 months.
Drug: Solanezumab
Administered Intravenously (IV)
Other Names:
  • LY2062430
  • A Beta Antibody
Placebo Comparator: Placebo
Placebo every 4 weeks for 18 months.
Drug: Placebo
Administered IV

  Eligibility

Ages Eligible for Study:   55 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Meets National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association (NINCDS/ADRDA) criteria for probable AD
  • Has a Modified Hachinski Ischemia Scale score of less than or equal to 4
  • Has a Mini-Mental State Examination (MMSE) score of 20 through 26 at Screening visit
  • Has a Geriatric Depression Scale score of less than or equal to 6 (on the staff-administered short form)
  • Has had a magnetic resonance imaging (MRI) or computerized tomography (CT) scan performed within the past 2 years that has confirmed no findings inconsistent with a diagnosis of AD
  • Has a florbetapir positron emission tomography (PET) scan or cerebrospinal fluid (CSF) result consistent with the presence of amyloid pathology at screening

Exclusion Criteria:

  • Does not have a reliable caregiver who is in frequent contact with the participant (defined as at least 10 hours per week), will accompany the participant to the office and/or be available by telephone at designated times, and will monitor administration of prescribed medications
  • Meets National Institute of Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS/AIREN) criteria for vascular dementia
  • Has current serious or unstable illnesses including cardiovascular, hepatic, renal, gastroenterologic, respiratory, endocrinologic, neurologic (other than AD), psychiatric, immunologic, or hematologic disease and other conditions that, in the investigator's opinion, could interfere with the analyses of safety and efficacy in this study; or has a life expectancy of <2 years
  • Has had a history within the last 5 years of a serious infectious disease affecting the brain or head trauma resulting in protracted loss of consciousness
  • Has a history within the last 5 years of a primary or recurrent malignant disease with the exception of resected cutaneous squamous cell carcinoma in situ, basal cell carcinoma, cervical carcinoma in situ, or in situ prostate cancer with a normal prostate-specific antigen posttreatment
  • Has a known history of human immunodeficiency virus (HIV), clinically significant multiple or severe drug allergies, or severe posttreatment hypersensitivity reactions
  • Has received acetylcholinesterase inhibitor (AChEIs), memantine and/or other AD therapy for less than 4 months or has less than 2 months of stable therapy on these treatments
  • Has received medications that affect the central nervous system (CNS), except treatments for AD, for less than 4 weeks
  • Has a history of chronic alcohol or drug abuse/dependence within the past 5 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01900665

Contacts
Contact: There may be multiple sites in this clinical trial 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559

  Hide Study Locations
Locations
United States, Arizona
Dedicated Clinical Research Active, not recruiting
Litchfield Park, Arizona, United States, 85351
Banner Alzheimer's Institute Recruiting
Phoenix, Arizona, United States, 85006
Contact    602-839-6979      
Principal Investigator: William Burke         
St Josephs Hospital and Medical Center Recruiting
Phoenix, Arizona, United States, 85013
Contact    602-406-4032      
Principal Investigator: Jiong Shi         
Xenoscience Recruiting
Phoenix, Arizona, United States, 85004
Contact    602-274-9500      
Principal Investigator: Stephen Flitman         
ANI Arizona Neurological Institute Research, PC Recruiting
Sun City, Arizona, United States, 85351
Contact    623-732-3800 ext 135      
Principal Investigator: Atul Syal         
Banner Sun Health Research Institute Recruiting
Sun City, Arizona, United States, 85351
Contact    623-832-6530      
Principal Investigator: Marwan Sabbagh         
Center for Neurosciences Recruiting
Tucson, Arizona, United States, 85718
Contact    520-320-2147      
Principal Investigator: Michael Badruddoja         
Arizona Health Sciences Center Recruiting
Tuscon, Arizona, United States, 85724
Contact    520-626-6524      
Principal Investigator: Geoffrey Ahern         
United States, California
American Neuropsychiatric Research Institute, Inc Recruiting
Carson, California, United States, 90746
Contact    310-329-2170      
Principal Investigator: Joseph Rodd         
Neurology Center of North Orange County Recruiting
Fullerton, California, United States, 92835
Contact    714-879-7200      
Principal Investigator: Stephen Waldman         
Institute for Memory Impairment & Neurological Disorders Recruiting
Irvine, California, United States, 92697
Contact    949-824-2382      
Principal Investigator: Aimee Pierce         
University of California - San Diego Recruiting
La Jolla, California, United States, 92037
Contact    858-246-1300      
Principal Investigator: Michael Rafii         
Senior Clinical Trials, Inc. Recruiting
Laguna Hills, California, United States, 92653
Contact    949-588-0909      
Principal Investigator: Robert Feldman         
Torrance Clinical Research Recruiting
Lomita, California, United States, 90717
Contact    310-373-8120      
Principal Investigator: Marina Raikhel         
Collaborative Neuroscience Network - CNS Recruiting
Long Beach, California, United States, 90806
Contact    916-934-0569      
Principal Investigator: Omid Omidvar         
Apostle Clinical Trials, Inc Recruiting
Long Beach, California, United States, 90813
Contact    562-437-4780      
Principal Investigator: Adly Thebaud         
UCLA Medical Center Recruiting
Los Angeles, California, United States, 90095
Contact    310-794-3231      
Principal Investigator: John Ringman         
Univ of Southern California Medical Center Recruiting
Los Angeles, California, United States, 90033
Contact    323-442-7600      
Principal Investigator: Lon Schneider         
University of California Los Angeles School of Medicine Recruiting
Los Angeles, California, United States, 90073
Contact    310-268-3708      
Principal Investigator: David Sultzer         
Hoag Memorial Hospital Recruiting
Newport Beach, California, United States, 92663
Contact    949-478-8858      
Principal Investigator: William Shankle         
Pacific Neuroscience Medical Group Recruiting
Oxnard, California, United States, 93030
Contact: Eli Lilly    877-285-4559      
Principal Investigator: James Sutton         
Anderson Clinical Research Recruiting
Redlands, California, United States, 92374
Contact    909-792-9007      
Principal Investigator: Donald Anderson         
University of California, Davis - Health Systems Recruiting
Sacramento, California, United States, 95817
Contact    916-734-5245      
Principal Investigator: John Olichney         
Sharp Mesa Vista Hospital Recruiting
San Diego, California, United States, 92123
Contact    858-836-8350      
Principal Investigator: Michael Plopper         
Pacific Research Network Inc Recruiting
San Diego, California, United States, 92103
Contact    619-294-4302      
Principal Investigator: Stephen Thein         
Artemis Institute for Clinical Research Recruiting
San Diego, California, United States, 92103
Contact    858-278-3647      
Principal Investigator: Ildiko Kovacs         
San Francisco Clinical Research Center Recruiting
San Francisco, California, United States, 94109
Contact    415-673-6400      
Principal Investigator: Jerome Goldstein         
University of California, San Francisco Recruiting
San Francisco, California, United States, 94158
Contact    415-476-0661      
Principal Investigator: Adam Boxer         
Apex Research Institute Recruiting
Santa Ana, California, United States, 92705
Contact    714-542-3008      
Principal Investigator: John Duffy         
St. Joseph Health Recruiting
Santa Rosa, California, United States, 95403
Contact    707-521-3830      
Principal Investigator: Allan Bernstein         
California Neuroscience Research Recruiting
Sherman Oaks, California, United States, 91403
Contact    818-990-2671      
Principal Investigator: Thomas Shiovitz         
United States, Colorado
Radiant Research Recruiting
Denver, Colorado, United States, 80239
Contact    303-477-1880      
Principal Investigator: John DeQuardo         
United States, Connecticut
Associated Neurologists of Southern Connecticut Recruiting
Fairfield, Connecticut, United States, 06824
Contact    203-333-1151      
Principal Investigator: Dario Zagar         
Yale University School of Medicine Recruiting
New Haven, Connecticut, United States, 06520-8020
Contact    203-764-8100      
Principal Investigator: Chris Van Dyck         
Institute for Neurodegenerative Disorders Recruiting
New Haven, Connecticut, United States, 06510
Contact    203-401-4349      
Principal Investigator: David Russell         
Research Center for Clinical Studies Recruiting
Norwalk, Connecticut, United States, 06851
Contact    203-838-0070      
Principal Investigator: Bart Sloan         
United States, Delaware
Christiana Care Research Institute Recruiting
Newark, Delaware, United States, 19713
Contact    302-731-1301      
Principal Investigator: Lanny Edelsohn         
United States, District of Columbia
Georgetown University Hospital Recruiting
Washington, District of Columbia, United States, 20057
Contact    202-687-7337      
Principal Investigator: Raymond Turner         
United States, Florida
Florida Atlantic University Recruiting
Boca Raton, Florida, United States, 33431
Contact    561-297-0164      
Principal Investigator: Peter Holland         
Parkinson's Disease and Movement Disorders Active, not recruiting
Boca Raton, Florida, United States, 33486
Quantum Laboratories Recruiting
Deerfield Beach, Florida, United States, 33064
Contact    954-786-7331      
Principal Investigator: Jose De La Gandar         
Brain Matters Research Recruiting
Delray Beach, Florida, United States, 33445
Contact    561-374-8461      
Principal Investigator: Mark Brody         
Cohen Medical Associates P.A. Recruiting
Delray Beach, Florida, United States, 33446
Contact    561-496-7200      
Principal Investigator: Robert Cohen         
Neuropsychiatric Research Center of Southwest Florida Recruiting
Fort Myers, Florida, United States, 33912
Contact    239-939-9777      
Principal Investigator: Frederick Schaerf         
MD Clinical Recruiting
Hallandale Beach, Florida, United States, 33009
Contact    954-455-5757      
Principal Investigator: Kerri Wilks         
Infinity Clinical Research . LLC Recruiting
Hollywood, Florida, United States, 33021
Contact    954-981-3850      
Principal Investigator: Harvey Schwartz         
Jacksonville Center for Clinical Research Recruiting
Jacksonville, Florida, United States, 32216
Contact    904-730-0101      
Principal Investigator: Erin Doty         
Mayo Clinic of Jacksonville Recruiting
Jacksonville, Florida, United States, 32224
Contact    904-953-7103      
Principal Investigator: Neil Graff-Radford         
New Horizon Research Center Active, not recruiting
Miami, Florida, United States, 33175
Miami Jewish Home and Hospital for the Aged Recruiting
Miami, Florida, United States, 33137
Contact    305-751-8626 ext 2403      
Principal Investigator: Marc Agronin         
Galiz Research Recruiting
Miami Springs, Florida, United States, 33166
Contact    305-805-0921      
Principal Investigator: Jose Gamez         
Renstar Medical Research Recruiting
Ocala, Florida, United States, 34471
Contact    352-629-5800      
Principal Investigator: Jay Rubin         
Compass Research Recruiting
Orlando, Florida, United States, 32806
Contact    407-426-9299      
Principal Investigator: Craig Curtis         
Neurology Clinical Research, Inc Recruiting
Sunrise, Florida, United States, 33351-6637
Contact    954-475-8171      
Principal Investigator: Richard Singer         
University of South Florida Recruiting
Tampa, Florida, United States, 33613
Contact    813-974-4355      
Principal Investigator: Balebail Raj         
Stedman Clinical Trials Recruiting
Tampa, Florida, United States, 33613
Contact    813-971-8311      
Principal Investigator: Mary Stedman         
Axiom Research Recruiting
Tampa, Florida, United States, 33609
Contact    813-353-9613      
Principal Investigator: Susan Steen         
Premiere Research Institute at Palm Beach Neurology Recruiting
West Palm Beach, Florida, United States, 33407
Contact    561-845-0500      
Principal Investigator: Walter Martinez         
United States, Georgia
Atlanta Center of Medical Research Recruiting
Atlanta, Georgia, United States, 30308
Contact    404-881-5800      
Principal Investigator: Robert Riesenberg         
Mercer University Active, not recruiting
Atlanta, Georgia, United States, 30341
United States, Illinois
Rush Alzheimer's Disease Center Recruiting
Chicago, Illinois, United States, 60612
Contact    312-942-2338      
Principal Investigator: Neelesh Aggarwal         
Alexian Brothers Medical Center Recruiting
Elk Grove Village, Illinois, United States, 60007
Contact    847-593-8553      
Principal Investigator: Concetta Forchetti         
United States, Indiana
Indiana University School of Medicine Recruiting
Indianapolis, Indiana, United States, 46202
Contact    317-963-4702      
Principal Investigator: Martin Farlow         
United States, Kansas
University of Kansas Medical Center Recruiting
Kansas City, Kansas, United States, 66160
Contact    913-588-0555      
Principal Investigator: Jeffrey Burns         
CTT Consultants Recruiting
Prairie Village, Kansas, United States, 66206
Contact    913-381-7180      
Principal Investigator: Haydn Thomas         
Heartland Research Associates Recruiting
Wichita, Kansas, United States, 67207
Contact    316-689-6629      
Principal Investigator: Dwight St Clair         
Via Christi Regional Medical Center Recruiting
Wichita, Kansas, United States, 67214
Contact    316-291-4774      
Principal Investigator: Paul Murphy         
United States, Kentucky
Baptist Physician's Lexington Recruiting
Lexington, Kentucky, United States, 40503
Contact    859-260-4330      
Principal Investigator: Greg Cooper         
United States, Louisiana
Louisiana Research Associates, Inc. Active, not recruiting
New Orleans, Louisiana, United States, 70114
Private Office: J. Gary Booker Recruiting
Shreveport, Louisiana, United States, 71104
Contact    318-277-9600      
Principal Investigator: James Booker         
United States, Maine
Maine Research Associates Recruiting
Auburn, Maine, United States, 04210
Contact    207-782-9835      
Principal Investigator: Mitchell Ross         
Maine Neurology Recruiting
Scarborough, Maine, United States, 04074
Contact    207-883-1414      
Principal Investigator: Eric Dinnerstein         
United States, Maryland
PharmaSite Research Inc Recruiting
Baltimore, Maryland, United States, 21208
Contact    410-602-1440      
Principal Investigator: Alan Jonas         
United States, Massachusetts
McLean Hospital Recruiting
Belmont, Massachusetts, United States, 02478
Contact    617-855-2532      
Principal Investigator: James Ellison         
Boston University Medical Center Recruiting
Boston, Massachusetts, United States, 02118
Contact    617-638-5678      
Principal Investigator: Robert Stern         
Brigham and Womens Hospital Recruiting
Boston, Massachusetts, United States, 02115
Contact    617-732-8085      
Principal Investigator: Gad Marshall         
Beacon Clinical Research, LLC Recruiting
Brockton, Massachusetts, United States, 02301
Contact    774-462-6610      
Principal Investigator: Dwight Chen         
ActivMed Practices & Research Recruiting
Methuen, Massachusetts, United States, 01844
Contact    978-655-7155      
Principal Investigator: Marc Shay         
Boston Center for Memory Recruiting
Newton, Massachusetts, United States, 02459
Contact    802-447-1409      
Principal Investigator: Paul Solomon         
United States, Michigan
Northern Michigan Neurology Recruiting
Traverse City, Michigan, United States, 49684
Contact    231-935-0340      
Principal Investigator: Bradley Evans         
United States, Mississippi
Hattiesburg Clinic Recruiting
Hattiesburg, Mississippi, United States, 39402
Contact    601-579-5345      
Principal Investigator: Ronald Schwartz         
United States, Missouri
St. Louis Research, Inc Not yet recruiting
St. Louis, Missouri, United States, 63118
Contact    314-771-6387      
Principal Investigator: Rick Mofsen         
United States, Nebraska
Univ of Nebraska Med Center Recruiting
Omaha, Nebraska, United States, 68198
Contact    402-559-4496      
Principal Investigator: Daniel Murman         
United States, Nevada
Cleveland Clinic of Las Vegas Recruiting
Las Vegas, Nevada, United States, 89106
Contact    702-483-6026      
Principal Investigator: Charles Bernick         
Las Vegas Radiology Recruiting
Las Vegas, Nevada, United States, 89113
Contact    310-493-9118      
Principal Investigator: Bharat Mocherla         
United States, New Jersey
AdvanceMed Research Recruiting
Lawrenceville, New Jersey, United States, 08648
Contact    609-895-0735      
Principal Investigator: Arnold Witte         
United States, New Mexico
Albuquerque Neurosciences Recruiting
Albuquerque, New Mexico, United States, 87109
Contact    505-848-3773      
Principal Investigator: Glenn Dempsey         
United States, New York
Albany Medical College Recruiting
Albany, New York, United States, 12206
Contact    518-459-8106      
Principal Investigator: David Hart         
Dent Neurological Institute Recruiting
Amherst, New York, United States, 14226
Contact    716-250-2000      
Principal Investigator: Horacio Capote         
SPRI Clinical Trials, LLC. Recruiting
Brooklyn, New York, United States, 11235
Contact    718-616-2400      
Principal Investigator: Nicholas Vatakis         
New York University Medical Center Recruiting
New York, New York, United States, 10016
Contact    212-263-3210      
Principal Investigator: Melanie Shulman         
Mount Sinai Medical Center Recruiting
New York, New York, United States, 10029-6574
Contact    212-241-8329      
Principal Investigator: Judith Neugroschl         
Columbia University Medical Center Recruiting
New York, New York, United States, 10032
Contact    212-305-9194      
Principal Investigator: Lawrence Honig         
Richmond Behavorial Associates Recruiting
Staten Island, New York, United States, 10312
Contact    718-317-5522      
Principal Investigator: Mark DiBuono         
United States, North Carolina
Behavioral Health Center Research Recruiting
Charlotte, North Carolina, United States, 28211
Contact    704-446-7504      
Principal Investigator: Oleg Tcheremissine         
PMG Research of Charlotte, LLC Recruiting
Charlotte, North Carolina, United States, 28203
Contact    704-527-6672      
Principal Investigator: Thor Borresen         
Guilford Neurologic Associates Recruiting
Greensboro, North Carolina, United States, 27405
Contact    336-273-2511      
Principal Investigator: Pramod Sethi         
Wake Research Associates Recruiting
Raleigh, North Carolina, United States, 27612
Contact    919-781-2514      
Principal Investigator: Jaishankar Jagadeesan         
PMG Research of Winston-Salem, LLC Recruiting
Winston-Salem, North Carolina, United States, 27103
Contact    336-768-8062      
Principal Investigator: Travis Jackson         
United States, Ohio
Valley Medical Research Recruiting
Centerville, Ohio, United States, 45459
Contact    937-208-8298      
Principal Investigator: Meenakshi Patel         
Ohio State Univ College Of Medicine Recruiting
Columbus, Ohio, United States, 43210
Contact    614-293-4969      
Principal Investigator: Douglas Scharre         
Neurology Specialists Inc. Recruiting
Dayton, Ohio, United States, 45417
Contact    937-495-0000      
Principal Investigator: Alan Jacobs         
Insight Clinical Trials Recruiting
Shaker Heights, Ohio, United States, 44122
Contact    216-526-1843      
Principal Investigator: Deborah Gould         
United States, Oklahoma
Cutting Edge Research Group Recruiting
Oklahoma City, Oklahoma, United States, 73116
Contact    405-603-8068      
Principal Investigator: Willis Holloway         
Red River Medical Center, LLC Recruiting
Oklahoma City, Oklahoma, United States, 73112
Contact    405-759-5600      
Principal Investigator: AMAL CHAKRABURTTY         
United States, Oregon
The Corvallis Clinic P.C. Recruiting
Corvallis, Oregon, United States, 97330
Contact    541-754-1274      
Principal Investigator: Richard Lafrance         
Summit Research Network Inc Recruiting
Portland, Oregon, United States, 97210
Contact    503-279-8252      
Principal Investigator: Scott Losk         
United States, Pennsylvania
Lehigh Center for Clinical Research Not yet recruiting
Allentown, Pennsylvania, United States, 18104
Contact    610-820-0342      
Principal Investigator: Paul Gross         
Drexel University College of Medicine at EPPI Recruiting
Philadelphia, Pennsylvania, United States, 19102
Contact    215-762-7090      
Principal Investigator: Carol Lippa         
University of Pittsburgh Medical Center Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact    412-692-2700      
Principal Investigator: Oscar Lopez         
United States, Rhode Island
Rhode Island Mood & Memory Research Institute Recruiting
East Providence, Rhode Island, United States, 02914
Contact    401-435-8950      
Principal Investigator: John Stoukides         
Butler Hospital Recruiting
Providence, Rhode Island, United States, 02906
Contact    401-455-6403      
Principal Investigator: Stephen Salloway         
Rhode Island Hospital Recruiting
Providence, Rhode Island, United States, 02903
Contact    401-444-6440      
Principal Investigator: Brian Ott         
United States, South Carolina
Roper St. Francis Healthcare Recruiting
Charleston, South Carolina, United States, 29401
Contact    843-724-2302      
Principal Investigator: Jacobo Mintzer         
Radiant Research Recruiting
Greer, South Carolina, United States, 29651
Contact    864-877-9239      
Principal Investigator: William Ellison         
United States, South Dakota
University Psychiatry Associates Avera Health Recruiting
Sioux Falls, South Dakota, United States, 57105
Contact    605-322-3705      
Principal Investigator: William Fuller         
United States, Tennessee
Quillen College of Medicine, East TN State University Recruiting
Johnson City, Tennessee, United States, 37604
Contact    423-439-2211      
Principal Investigator: Norman Moore         
Vanderbilt Univeristy School of Medicine Recruiting
Nashville, Tennessee, United States, 37212
Contact    615-936-0928      
Principal Investigator: Paul Newhouse         
United States, Texas
University of Texas Southwestern Medical Center at Dallas Recruiting
Dallas, Texas, United States, 75390
Contact    214-648-3105      
Principal Investigator: Mary Quiceno         
Texas Neurology, PA Recruiting
Dallas, Texas, United States, 75214
Contact    214-827-3610      
Principal Investigator: Charles Greenfield         
FutureSearch Trials Active, not recruiting
Dallas, Texas, United States, 75231
Innovative Clinical Trials Recruiting
San Antonio, Texas, United States, 78205
Contact    210-377-2873      
Principal Investigator: James Garrison         
United States, Utah
Radiant Research Recruiting
Murray, Utah, United States, 84123
Contact    801-261-8930      
Principal Investigator: Mark Johnston         
University of Utah School of Medicine Recruiting
Salt Lake City, Utah, United States, 84108
Contact    801-587-7857      
Principal Investigator: Edward Zamrini         
United States, Vermont
The Memory Clinic Recruiting
Bennington, Vermont, United States, 05201
Contact    413-281-0577      
Principal Investigator: Cynthia Murphy         
United States, Virginia
National Clinical Research - Norfolk Inc Recruiting
Norfolk, Virginia, United States, 23502
Contact    757-461-3633 ext 3214      
Principal Investigator: Barry Lubin         
National Clinical Research - Richmond Recruiting
Richmond, Virginia, United States, 23294
Contact    804-467-2995      
Principal Investigator: John Hoekstra         
Blue Ridge Research Center Recruiting
Roanoke, Virginia, United States, 24018
Contact    540-342-2929      
Principal Investigator: John Burch         
United States, Washington
Veterans Affairs Puget Sound Health Care System Recruiting
Seattle, Washington, United States, 98108
Contact    206-764-2002      
Principal Investigator: Elaine Peskind         
Australia, New South Wales
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Darlinghurst, New South Wales, Australia, 2010
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
East Gosford, New South Wales, Australia, 2250
Contact: Eli Lilly         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Kogarah, New South Wales, Australia, 2217
Contact: Eli Lilly         
Australia, Queensland
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Chermside, Queensland, Australia, 4032
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Herston, Queensland, Australia, 4029
Contact: Eli Lilly         
Australia, Victoria
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Box Hill, Victoria, Australia, 3128
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Caulfield, Victoria, Australia, 3162
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Fitzroy, Victoria, Australia, 3065
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Heidelberg, Victoria, Australia, 3081
Contact: Eli Lilly and Company         
Australia, Western Australia
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Subiaco, Western Australia, Australia, 06008
Contact: Eli Lilly and Company         
Canada, Alberta
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Medicine Hat, Alberta, Canada, T1B4E7
Contact: Eli Lilly and Company         
Canada, Ontario
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
London, Ontario, Canada, N6C 5J1
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Ottawa, Ontario, Canada, K1N 5C8
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Peterborough, Ontario, Canada, K9H2P4
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Toronto, Ontario, Canada, M6M 3Z5
Contact: Eli Lilly and Company         
Canada, Quebec
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Gatineau, Quebec, Canada, J8T 8J1
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Greenfield Park, Quebec, Canada
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Sherbrooke, Quebec, Canada, J1H1Z1
Contact: Eli Lilly and Company         
France
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Bron, France, 69677
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Dijon, France, 21033
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Lille, France, 59037
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Marseille, France, 13385
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Montpellier, France, 34295
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Paris, France, 75013
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Reims, France, 51092
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Rennes, France, 35033
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Strasbourg, France, 67098
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Toulouse, France, 31059
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Villeurbanne, France, 69100
Contact: Eli Lilly and Company         
Germany
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Berlin, Germany, 14050
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Boeblingen, Germany, 71034
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Active, not recruiting
Dresden, Germany, 01307
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Hannover, Germany, 30559
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Mannheim, Germany, 68165
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Munich, Germany, 81675
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Siegen, Germany, 57076
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Ulm, Germany, 89081
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Westerstede, Germany, 26655
Contact: Eli Lilly and Company         
Italy
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Biella, Italy, 13900
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Firenze, Italy, 50134
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Genova, Italy, 16128
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Milano, Italy, 20122
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Perugia, Italy, 06156
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Pisa, Italy, 56126
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Rome, Italy, 00161
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Torino, Italy, 10126
Contact: Eli Lilly and Company         
Japan
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Aichi, Japan, 474-8511
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Hyogo, Japan, 670-0981
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Ibaraki, Japan, 305-8576
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Kanagawa, Japan, 247-8533
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Kobe, Japan, 655-0037
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Kyoto, Japan, 616-8255
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Osaka, Japan, 545-8586
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Shizuoka, Japan, 424-8636
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Tokushima, Japan, 770-8503
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Tokyo, Japan, 187-8551
Contact: Eli Lilly and Company         
Poland
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Bydgoszcz, Poland, 85-796
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Katowice, Poland, 40-588
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Krakow, Poland, 31-505
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Sopot, Poland, 81-824
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Szczecin, Poland, 70-215
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Warsaw, Poland, 01-813
Contact: Eli Lilly and Company         
Spain
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Barakaldo, Spain, 48903
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Barcelona, Spain, 08014
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Getafe, Spain, 28905
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Guipuzcoa, Spain, 20014
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Madrid, Spain, 28006
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Plasencia, Spain, 10600
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Salt-Girona, Spain, 17190
Contact: Eli Lilly and Company         
Sweden
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Jönköping, Sweden, 55185
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Malmo, Sweden, 212 24
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Molndal, Sweden, 431 41
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Stockholm, Sweden, 14186
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Umea, Sweden, 90185
Contact: Eli Lilly and Company         
United Kingdom
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Bath, Avon, United Kingdom, BA1 3NG
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Plymouth, Devon, United Kingdom, PL6 8BX
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Crowborough, East Sussex, United Kingdom, TN6 1HB
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Scotland, Glasgow, United Kingdom, G20 0XA
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Greater London, London, United Kingdom, W1G9JF
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Salford, Manchester, United Kingdom, M6 8HD
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Swindon, Wiltshire, United Kingdom, SN3 6BW
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Glasgow, United Kingdom, G31 2ER
Contact: Eli Lilly and Company         
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Recruiting
Newcastle, United Kingdom, NE4 5PL
Contact: Eli Lilly and Company         
Sponsors and Collaborators
Eli Lilly and Company
Investigators
Study Director: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) Eli Lilly and Company
  More Information

No publications provided

Responsible Party: Eli Lilly and Company
ClinicalTrials.gov Identifier: NCT01900665     History of Changes
Other Study ID Numbers: 15136, H8A-MC-LZAX
Study First Received: July 12, 2013
Last Updated: October 10, 2014
Health Authority: Australia: Department of Health and Ageing Therapeutic Goods Administration
Canada: Health Canada
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Germany: Paul-Ehrlich-Institut
Italy: The Italian Medicines Agency
Japan: Pharmaceuticals and Medical Devices Agency
Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products
Spain: Agencia Española de Medicamentos y Productos Sanitarios
Sweden: Medical Products Agency
United Kingdom: Medicines and Healthcare Products Regulatory Agency
United States: Food and Drug Administration

Additional relevant MeSH terms:
Alzheimer Disease
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Nervous System Diseases
Neurodegenerative Diseases
Tauopathies

ClinicalTrials.gov processed this record on November 20, 2014